Effects of different CpG oligodeoxynucleotides with inactivated avian H5N1 influenza virus on mucosal immunity of chickens

Poultry Science

Volumn 92, Issue 11, 2013, Pages 2866-2875

  Fu, Jia ^a   Liang, Jinfeng ^a   Kang, Haihong ^a   Lin, Jian ^a   Yu, Qinghua ^a   Yang, Qian ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

Author keywords

Avian H5N1 influenza virus; Avian Toll like receptor; CpG oligodeoxynucleotide; Intranasal immunization; Virus challenge

Indexed keywords

AVES; AVIAN INFLUENZA VIRUS; GALLUS GALLUS; ORTHOMYXOVIRIDAE;

EID: 84885935547     PISSN: 00325791     EISSN: 15253171     Source Type: Journal    
DOI: 10.3382/ps.2013-03205     Document Type: Article

References (26)

1. Ameiss, K. A., J. El Attrache, A. Barri, A. P. McElroy, and D. J. Caldwell. 2006. Influence of orally administered CpG-ODNs on the humoral response to bovine serum albumin (BSA) in chickens. Vet. Immunol. Immunopathol. 110:257-267. http://dx.doi. org/10.1016/j.vetimm.2005.10.011.
2. Beutler, B. 2003. Innate immune responses to microbial poisons: Discovery and function of the toll-like receptors. Annu. Rev. Pharmacol. 43:609-628.
3. Brownlie, R., J. Z. Zhu, B. Allan, G. K. Mutwiri, L. A. Babiuk, A. Potter, and P. Griebel. 2009. Chicken TLR21 acts as a functional homologue to mammalian TLR9 in the recognition of CpG oligodeoxynucleotides. Mol. Immunol. 46:3163-3170. http://dx.doi. org/10.1016/j.molimm.2009.06.002.
4. Dalpke, A. H., and K. Heeg. 2004. CpG-DNA as immune response modifier. Int. J. Med. Microbiol. 294:345-354. http://dx.doi. org/10.1016/j.ijmm.2004.07.005.
5. Dalpke, A. H., S. Zimmermann, I. Albrecht, and K. Heeg. 2002. Phosphodiester CpG oligonucleotides as adjuvants: Polyguanosine runs enhance cellular uptake and improve immunostimulative activity of phosphodiester CpG oligonucleotides in vitro and in vivo. Immunology 106:102-112.
6. Du, H. Y., S. Y. Xia, H. F. Song, N. Li, M. M. Shang, J. Zou, Q. Q. Wang, L. Ou, X. Sun, A. G. Ji, and Z. M. Tang. 2007. Structure-efficacy relationships of immunostimulatory activity of CpG-containing oligodeoxynucleotides on mouse spleen cells. Acta Pharmacol. Sin. 28:1637-1644. http://dx.doi.org/10.1111/ j.1745-7254.2007.00628.x.
7. Fukuiwa, T., S. Sekine, R. Kobayashi, H. Suzuki, K. Kataoka, R. S. Gilbert, Y. Kurono, P. N. Boyaka, A. M. Krieg, J. R. McGhee, and K. Fujihashi. 2008. A combination of Flt3 ligand cDNA and CpG ODN as nasal adjuvant elicits NALT dendritic cells for prolonged mucosal immunity. Vaccine 26:4849-4859. http://dx.doi. org/10.1016/j.vaccine.2008.06.091.
8. Heine, H., and E. Lien. 2003. Toll-like receptors and their function in innate and adaptive immunity. Int. Arch. Allergy Immunol. 130:180-192. http://dx.doi.org/10.1159/000069517.
9. Kang, H., H. Wang, Q. Yu, and Q. Yang. 2012. Effect of intranasal immunization with inactivated avian influenza virus on local and systemic immune responses in ducks. Poult. Sci. 91:1074-1080. http://dx.doi.org/10.3382/ps.2011-01817.
10. Keestra, A. M., M. R. de Zoete, L. I. Bouwman, and J. P. M. van Putten. 2010. Chicken TLR21 is an innate CpG DNA receptor distinct from mammalian TLR9. J. Immunol. 185:460-467. http://dx.doi.org/10.4049/jimmunol.0901921.
11. OIE (Office International Des Epizootics). 2005. Manual of diagnostic tests and vaccines for terrestrial animals. http://www.oie.int.
12. Petrovsky, N., and J. C. Aguilar. 2004. Vaccine adjuvants: Current state and future trends. Immunol. Cell Biol. 82:488-496. http:// dx.doi.org/10.1111/j.0818-9641.2004.01272.x.
13. Pfaffl, M. W. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45.
14. Pun, P. B., A. A. Bhat, T. Mohan, S. Kulkarni, R. Paranjape, and D. N. Rao. 2009. Intranasal administration of peptide antigens of HIV with mucosal adjuvant CpG ODN coentrapped in microparticles enhances the mucosal and systemic immune responses. Int. Immunopharmacol. 9:468-477. http://dx.doi.org/10.1016/j.intimp. 2009.01.012.
15. Roh, H. J., H. W. Sung, and H. M. Kwon. 2006. Effects of DDA, CpG-ODN, and plasmid-encoded chicken IFN-gamma on protective immunity by a DNA vaccine against IBDV in chickens. J. Vet. Sci. 7:361-368.
16. Scheerlinck, J. P. Y., S. Gekas, H. H. Yen, S. Edwards, M. Pearse, A. Coulter, and P. Sutton. 2006. Local immune responses following nasal delivery of an adjuvanted influenza vaccine. Vaccine 24:3929-3936. http://dx.doi.org/10.1016/j.vaccine.2006.02.032.
17. Taghavi, A., B. Allan, G. Mutwiri, M. Foldvari, A. Van Kessel, P. Willson, L. Babiuk, A. Potter, and S. Gomis. 2009. Enhancement of immunoprotective effect of CpG-ODN by formulation with polyphosphazenes against E. coli septicemia in neonatal chickens. Curr. Drug Deliv. 6:76-82.
18. Temperley, N. D., S. Berlin, I. R. Paton, D. K. Griffin, and D. W. Burt. 2008. Evolution of the chicken Toll-like receptor gene family: A story of gene gain and gene loss. BMC Genomics http:// dx.doi.org/10.1186/1471-2164-9-62.
19. Thompson, A. L., and H. F. Staats. 2011. Cytokines: The future of intranasal vaccine adjuvants. Clin. Dev. Immunol. http:// dx.doi.org/10.1155/2011/289597.
20. Wang, X., P. Jiang, S. Deen, J. Wu, X. Liu, and J. Xu. 2003. Efficacy of DNA vaccines against infectious bursal disease virus in chickens enhanced by coadministration with CpG oligodeoxynucleotide. Avian Dis. 47:1305-1312.
21. Wang, Y. M., C. Q. Shan, S. X. Ming, Y. Liu, Y. C. Du, and G. T. Jiang. 2009. Immunoadjuvant effects of bacterial genomic DNA and CpG oligodeoxynucleotides on avian influenza virus subtype H5N1 inactivated oil emulsion vaccine in chicken. Res. Vet. Sci. 86:399-405. http://dx.doi.org/10.1016/j.rvsc.2008.09.006.
22. Xiang, X. X., X. Q. Zhou, Q. Xie, H. Yu, and H. J. Zhou. 2008. [Effects of CpG-ODN combined with HBsAg on the phenotype, function and the activity of NF-kappa B and AP-1 of monocytederived dendritic cells in chronic hepatitis B patients]. Chin. J. Hepatol. 16:97-100.
23. Xiaowen, Z., Y. Qinghua, Z. Xiaofei, and Y. Qian. 2009. Co-administration of inactivated avian influenza virus with CpG or rIL-2 strongly enhances the local immune response after intranasal immunization in chicken. Vaccine 27:5628-5632. http://dx.doi. org/10.1016/j.vaccine.2009.07.023.
24. Yang, C., H. Shi, J. Zhou, Y. Liang, and H. Xu. 2009. CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus. Vaccine 27:6558-6563. http://dx.doi.org/10.1016/j.vaccine.2009.08.047.
25. Zhou, F., G. Q. Wang, P. Buchy, Z. P. Cai, H. L. Chen, Z. W. Chen, G. H. Cheng, X. F. Wan, V. Deubel, and P. Zhou. 2012. A triclade DNA vaccine designed on the basis of a comprehensive serologic study elicits neutralizing antibody responses against all clades and subclades of highly pathogenic avian influenza H5N1 viruses. J. Virol. 86:6970-6978.
26. Zuercher, A. W. 2003. Upper respiratory tract immunity. Viral Immunol. 16:279-289.